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Abstract 
Background: There is an increasing appreciation for a series of less traditional risk factors that should not be ignored 
when considering type 2 diabetes, obesity, hypertension, and cardiovascular disease. These include aortic stiffness, 
cardiac structure, impaired endothelial function and obstructive sleep apnea. They are associated to varying degrees 
with each disease categorization and with each other. It is not clear whether they represent additional complications, 
concomitants or antecedents of disease. Starr County, Texas, with its predominantly Mexican American population 
has been shown previously to bear a disproportionate burden of the major disease categories, but little is known 
about the distribution of these less traditional factors.
Methods: Type 2 diabetes, obesity and hypertension frequencies were determined through a systematic survey of 
Starr County conducted from 2002 to 2006. Individuals from this examination and an enriched set with type 2 diabe-
tes were re-examined from 2010 to 2014 including assessment of cardiac structure, sleep apnea, endothelial function 
and aortic stiffness. Individual and combined frequencies of these inter-related (i.e., axis) conditions were estimated 
and associations evaluated.
Results: Household screening of 5230 individuals aged 20 years and above followed by direct physical assessment 
of 1610 identified 23.7 % of men and 26.7 % of women with type 2 diabetes, 46.2 and 49.5 % of men and women, 
respectively with obesity and 32.1 and 32.4 % with hypertension. Evaluation of pulse wave velocity, left ventricular 
mass, endothelial function and sleep apnea identified 22.3, 12.7, 48.6 and 45.2 % of men as having “at risk” values for 
each condition, respectively. Corresponding numbers in women were 16.0, 17.9, 23.6 and 28.8 %. Cumulatively, 88 % 
of the population has one or more of these while 50 % have three or more.
Conclusions: The full axis of conditions is high among Mexican Americans in Starr County, Texas. Individual and joint 
patterns suggest a genesis well before overt disease. Whether they are all mediated by common underlying factors or 
whether there exist multiple mechanisms remains to be seen.
Keywords: Type 2 diabetes, Obesity, Hypertension, Aortic stiffness, Endothelial function, Sleep apnea, Left ventricular 
mass, Prevalence, Hispanic, Mexican American
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Background
Accumulating evidence establishes a series of less tra-
ditional risk factors not to be ignored in considerations 
of diabetes, obesity, hypertension, and cardiovascular 
disease. These factors include aortic stiffness, cardiac 
structure, impaired endothelial function, obstructive 
sleep apnea, coronary artery calcification, carotid intima-
media thickness and ankle/brachial index. They vary 
in difficulty in their implementation and appear to be 
associated to varying degrees with each disease catego-
rization and with each other [1–5], but it is not clear 
whether they represent additional complications or con-
comitants of disease. There are few reports of their com-
bined impact in the general population and even less in 
the Hispanic population. We report here the individual 
age- and sex-specific impacts of type 2 diabetes, obe-
sity, hypertension, aortic stiffness, left ventricular hyper-
trophy, impaired endothelial function and sleep apnea 
among Mexican Americans in Starr County, Texas. We 
also report their associations with each other, with predi-
abetes and normal glycemia and their cumulative impact. 
These results, coupled with those now reported from the 
Hispanic Community Health Study/Study of Latinos for 
the traditional factors [6, 7] and sleep disordered breath-
ing [8], clearly demonstrate an underappreciated and 
under-targeted burden of disease.
As we age, arterial stiffness increases [9] leading to 
increased central pressure and left ventricular load that 
likely contribute to left ventricular hypertrophy [10] and 
may independently predict cardiovascular events [11]. 
These processes seem to be exacerbated in type 2 dia-
betes [12]. Left ventricular hypertrophy [13], in particu-
lar, is a consequence of hypertension and independently 
predicts coronary heart disease and heart failure [14]. It 
shows associations with diabetes [14], sleep apnea [15] 
and pulse wave velocity [16]. Changes in the regulatory 
capacity of the endothelium can also lead to increased 
aortic stiffness [17]. Arterial stiffness has been reported 
to be associated with obstructive sleep apnea [1, 3, 5, 18].
Impaired endothelial function has been demonstrated 
in individuals with prediabetes and diabetes [19, 20]. 
Worsening endothelial function appears to be linearly 
associated with dysglycemia even in the absence of overt 
diabetes [19] and is “ubiquitous” at all levels of insulin 
resistance and diabetes [21]. Furthermore, endothe-
lial dysfunction is a common concomitant of obstruc-
tive sleep apnea [22, 23]. Among the largest and earliest 
efforts to understand the epidemiology of obstructive 
sleep apnea was the Sleep Heart Health Study estab-
lished in 1994 [15, 24]. It and other studies make it clear 
that sleep apnea is intimately intertwined with an axis of 
non-traditional risk factors. It is associated with type 2 
diabetes [3, 25], hypertension, cardiac morphology and 
cardiovascular disease [1, 17], obesity [5, 8] and all-cause 
mortality [26].
These non-traditional risk factors provide key physio-
logic targets where understanding their biological under-
pinnings could have substantial impact on developing 
strategies to slow the progression and prevent several 
chronic conditions. Recognition of their contribution is a 
relatively recent phenomenon and additional population 
data are needed across most ethnic groups. While each 
factor could be reported in isolation, it is important that 
their cumulative role and relationships be reported at a 
higher level. Here we report the impact of type 2 diabe-
tes, obesity, hypertension, aortic stiffness, left ventricular 
mass, reactive hyperemia and sleep apnea among Mexi-
can Americans obtained from systematic evaluation of 
the population of Starr County, Texas. The overall burden 
and relationships among these factors point to a stagger-
ing burden of chronic disease with underlying common-
alities and unique relationships among them.
Methods
Study design
The data presented were generated in three phases; an 
enumeration of households, detailed examination of 
selected individuals, and follow-up examinations. A flow 
chart of the sampling is presented in Fig.  1. From 2002 
to 2004 we performed a systematic enumeration of 2507 
households from 309 blocks selected randomly from the 
major population centers of Starr County. This led to the 
identification of 8729 individuals (14.9 % of the estimated 
2004 population of Starr County) largely representative 
of the age and sex distribution of the overall population. 
Diabetes status by history was determined for all but one 
individual.
From each household, one individual aged 20–50 years 
and not previously diagnosed with diabetes was ran-
domly selected for a physical evaluation following an 
overnight fast that included medical and demographic 
history, anthropometry, EKG and blood pressure meas-
urement and an oral glucose tolerance test using a 75 g 
glucose load with sampling at 0, 30, 60, 90 and 120 min 
post-load. A total of 1251 individuals were examined. An 
additional 94 individuals over the age of 50  years with-
out a previous diagnosis of diabetes were also examined 
to give estimates of the undetected load of abnormal 
glucose tolerance among older individuals bringing the 
total examined with this protocol to 1345. These exami-
nations occurred from 2002 to 2006. Glucose levels 
were determined at our field site, in duplicate, using an 
YSI 2300 STAT Plus Glucose & Lactate Analyzer (YSI 
Life Sciences, Yellow Springs, Ohio). Blood pressure was 
measured three times following a 5 min period of sitting 
rest using a Hawksley random zero sphygmomanometer 
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(Hawksley and Sons, Lancing, UK). The average systolic 
and diastolic pressures from the second and third meas-
urements were used as an individual’s pressures.
From the household enumeration, 265 individuals 
with a history of diabetes and currently taking glucose 
lowering medications were enrolled and examined in 
an ongoing study of the genetics of type 2 diabetes and 
its complications. There were also 50 newly diagnosed 
cases of diabetes based on the oral glucose tolerance 
testing that were rolled into these genetic studies. These 
examinations shared protocols with the exceptions that 
no glucose tolerance tests were performed and sensitive 
eye examinations were added for classification of diabetic 
retinopathy [27].
Individuals participating in the oral glucose tolerance 
tests (n =  1345) and all those with type 2 diabetes par-
ticipating in the genetics of diabetes studies (n =  1039) 
formed the pool of subjects eligible for a follow-up exam-
ination from December 2010 to January 2014. All were 
classified as Mexican American. These follow-up exami-
nations were expanded in scope. The oral glucose toler-
ance was modified to add 10 and 20 min sampling points 
for those without diabetes. Echocardiography, evaluation 
of aortic stiffness, and assessment of reactive hyperemia 
and sleep apnea were also added. A target sample size of 
1200 for these follow-up examinations was set with the 
intent of sampling equal numbers of those with and with-
out diabetes. Sampling from the 1345 having an earlier 
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Fig. 1 Flow diagram summarizing the household survey and two examination rounds of selected individuals
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oral glucose tolerance test continued until nearly 600 
individuals remaining free of diabetes were examined. 
This sampling also identified 170 incident cases of type 
2 diabetes from this group. To complete the targeted 600 
individuals with type 2 diabetes, we examined 432 indi-
viduals with diabetes from our genetic studies. The final 
sample with follow-up examinations consisted of 598 
individuals without diabetes and 602 individuals with 
type 2 diabetes (Fig. 1).
Standard 2D and Doppler echocardiographic meas-
ures were obtained using an Acuson Cypress (Siemens 
Medical Solutions, Mountain View, CA) and protocols 
reported previously [28]. As a measure of aortic stiff-
ness, pulse wave velocity in meters per second (PWV) 
was determined from the common carotid to the femo-
ral artery using the validated SphygmoCor CPV Sys-
tem (AtCor Medical, Sydney, Australia) [29] according 
to manufacturer recommendations. Transit distance 
for calculation of pulse wave velocity was determined 
by subtracting the distance from the carotid location to 
the sternal notch from the distance between the sternal 
notch and the femoral measurement site. Reactive hyper-
emia was measured as a surrogate for endothelial func-
tion using an EndoPat 2000 (Itamar Medical, Caesarea, 
Israel) to measure digital peripheral arterial tonometry 
changes following 5  min of brachial occlusion with a 
standard blood pressure cuff according to manufacturer 
recommendations. This method has been shown to be 
reproducible [30], less prone to operator variability [31] 
and highly correlated with brachial flow-mediated dila-
tion [32].
An overnight, in-home sleep evaluation was per-
formed using the WatchPat 200 monitor (Itamar Medi-
cal, Caesarea, Israel) based on digital peripheral arterial 
tonometry which has been shown to correlate well with 
polysomnography [33]. Sleep recordings were manu-
ally reviewed to ensure consistent identification of sleep, 
wake and artifact. The primary metric was the algorithm 
derived estimated apnea hypopnea index (AHI; number 
of respiratory disturbances per hour of estimated sleep). 
Blood pressure was measured three times following a 
5  min sitting rest using an automated device (Critikon 
Dinamap, Tampa, FL) with the average of the second and 
third values used as the final measures.
Disease and non‑traditional risk factor definitions
Previously identified diabetes was based on a positive 
response to being asked if a health care professional had 
ever told the individual that they had diabetes. Individuals 
undergoing a physical evaluation were classified with dia-
betes based on a fasting glucose of 126 mg/dl or greater 
or a 2 h post-load glucose of 200 or greater or a previous 
diagnosis of diabetes and current use of glucose lowering 
medications according to current guidelines [34]. We 
used the same guidelines to classify those with impaired 
fasting glucose (100–125  mg/dl) or impaired glucose 
tolerance (2 h glucose of 140–199 mg/dl) as having pre-
diabetes. In our most recent examination, all individu-
als were measured for HbA1c (Siemens DCA Vantage 
Analyzer point of care device, Malvern, PA) allowing 
additional classification of diabetes (HbA1c ≥  6.5  %) or 
prediabetes (5.7 ≤ HbA1c ≤ 6.4 %) [34].
Overweight was defined as a body mass index (BMI, 
weight in kilograms divided by the square of height in 
meters) of 25 or more, but less than 30 while obesity was 
defined as a BMI of 30 or more [35]. Hypertension was 
classified as a systolic blood pressure (average of the sec-
ond and third measures) of 140  mmHg or greater or a 
diastolic pressure of 90 or greater or current use of anti-
hypertensive medications [36]. Individuals were classi-
fied with significant aortic stiffness based on a pulse wave 
velocity of 12 or greater [37]. A digital pulse reactive 
hyperemia index (RHI) of less than 1.67 was taken as evi-
dence of a significant deficit according to manufacturer 
recommendations and as used in other settings [38]. Left 
ventricular (LV) mass was calculated from 2D measures 
and indexed to height in meters raised to the 2.7 power 
as detailed in Lang et al. [13] and rounded to the nearest 
whole. Mild, moderate and severe LV mass abnormali-
ties were classified using sex-specific reference values 
(45–51, 52–58, 59+  g/m2.7, respectively for women and 
49–55, 56–63 and 64+ g/m2.7, respective for men) from 
[13]. Owing to an equipment failure that led to sev-
eral months without an echocardiograph, LV mass was 
obtained on only 733 subjects. Mild, moderate and severe 
sleep apnea were defined based on an AHI of 5, 15 and 
30 or more, respectively [8]. Individuals reporting regular 
or intermittent use of a CPAP device were also classified 
as having severe sleep apnea. Among those with diabetes 
were a number of individuals that were older and frailer. 
These individuals were examined either in their homes or 
nursing facilities. As a result, their examinations included 
only a subset of the protocols that did not require the 
equipment in our field office.
Statistical analysis
Frequencies of diabetes, prediabetes, overweight, obesity 
and hypertension come from the household survey cou-
pled with the concurrent individual examinations (Fig. 1). 
Because the sampling involved those with and with-
out diabetes separately, the final frequencies represent 
weighted frequencies reflective of the population distri-
bution of those with and without diabetes. Sampling in 
the 2010–2014 follow-up examinations results in a rep-
resentative sample of those without diabetes and a rep-
resentative sample with diabetes, but the overall sample 
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is no longer representative of the frequencies in the total 
population. We employ a similar weighting strategy as 
above accounting for the expected distribution of diabe-
tes in the population for generating overall frequencies 
and show in figures and supplemental tables the impact 
of diabetes on all of these conditions.
Data are generally presented as frequencies stratified 
by sex, age group or disease classifications. Differences in 
frequencies among men and women are tested with the 
Mantel-Haenzel Chi square controlling for the effects of 
age groupings [39]. To examine the relationships between 
the multiple factors, a series of logistic regressions [40] 
were performed. Because near complete data were avail-
able for age, sex, diabetes, obesity and hypertension, 
these factors were always included in the logistic models 
except when they were being treated as the independent 
variable. Thus, the significance of any factor was deter-
mined in the context of adjustment for age, sex, diabe-
tes, obesity and hypertension. This strategy maximized 
the sample size available for each analysis. When a factor 
was the dependent variable, each was dichotomized as 
follows: diabetes—yes or no; obesity—BMI ≥ 30 or not; 
LV mass—moderate and severe versus not; sleep apnea—
AHI ≥ 30 or not. When analyzed as an independent vari-
able, the full groupings were used.
Results
Tables  1 and 2 detail the frequencies by age and sex of 
the full axis of traditional and non-traditional risk fac-
tors. In Table 1, age- and sex-specific prevalences of the 
traditional factors, type 2 diabetes, obesity and hyper-
tension, are documented while Table 2 tabulates the less 
traditional factors of aortic stiffness, LV mass, reactive 
hyperemia and sleep apnea. Previously diagnosed diabe-
tes comes from the 5230 individuals aged 20 and above in 
the representative household survey of the Starr County 
Mexican American population. An additional 3498 indi-
viduals were less than age 20 with diabetes reported for 
only five of them. Of the 648 individuals classified as 
having diabetes in the household enumerations, only 
one was consistent with type 1 diabetes based on an age 
at diagnosis under the age of 20, continuous insulin use 
since diagnosis and normal weight. All others were con-
sidered to have type 2 diabetes. No significant differences 
between men and women were seen for any of the diabe-
tes related classifications. While the overall proportions 
of men and women with a BMI of 25 or greater were sim-
ilar, men were significantly more often overweight and 
significantly less often obese than women after control-
ling for age group. Men were also significantly more often 
hypertensive than women, but only moderately so.
The less commonly considered factors in Table 2 indi-
cate a much more complex disease burden than the 
presence of diabetes, obesity and hypertension. The Man-
tel–Haenszel Chi squares indicate significant differences 
by sex for the most increased LV mass category, impaired 
endothelial function and severe sleep apnea (AHI ≥ 30) 
after controlling for age. It is likely that these difference 
are reflective of differential distributions of the array of 
factors and these will be examined in more detail below. 
Additional file 1: Tables S1 and S2 provide data equiva-
lent to Table 2 for those without and with type 2 diabetes, 
respectively.
There were 705 individuals without diabetes during the 
first examination (2002–2006) that were reexamined in 
2010–2014. From this group, we detected 107 incident 
cases of type 2 diabetes during the average 8.5 year fol-
low-up period yielding an incidence of 107/5978 person 
years or an annual incidence of 1.79 % (95 % confidence 
interval  =  1.48–2.16  %). The annual incidence in those 
with prediabetes at the first examination was 3.48  % 
(2.80–4.3  %), fivefold higher than the 0.67  % (0.45–
1.00 %) in those with normal glucose tolerance. Although 
HbA1c was not available during the first examination, we 
note that three additional individuals would be classified 
as having diabetes based on their HbA1c values at the 
follow-up examination.
Strengths of associations among conditions are in 
Table  3 where the odds ratios and significance from 
logistic regression are presented. The conditions most 
commonly considered, type 2 diabetes, obesity and 
hypertension, all show strong associations with one 
another. The strongest associations were between obesity 
and sleep apnea category (odds ratio =  3.16, p < 0.001) 
and type 2 diabetes and hypertension (odds ratio = 3.60, 
p < 0.001). Type 2 diabetes is also significantly associated 
with aortic stiffness and LV mass indexed for height after 
adjusting for age, sex, obesity and hypertension. In addi-
tion to sleep apnea, obesity is strongly associated with 
LV mass indexed for height while hypertension shows 
significant associations with all four non-traditional risk 
factors. Within the non-traditional risk factors, any asso-
ciations among them seem to be largely explained already 
by their associations with age, sex, diabetes, obesity and 
hypertension. The exception is that LV mass shows a sig-
nificant association with sleep apnea (odds ratio = 1.31, 
p < 0.05).
Interviewer obtained data identified 138 individuals 
with prevalent cardiovascular disease based on a history 
of heart attack, angina, bypass surgery or stents. All but 
17 of these individuals were in the group with diabetes 
who were significantly older than those without diabe-
tes. Logistic regression was performed similarly to that 
in Table  3 with age, obesity and hypertension forced in 
a model to predict cardiovascular disease history and 
each non-traditional factor considered one at a time in 
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analyses limited to those with type 2 diabetes. Of the 
non-traditional factors, LV mass showed a significant 
association with heart disease history after adjusting 
for the other factors (odds ratio =  1.44, p < 0.05) while 
the odds ratios for elevated pulse wave velocity (1.77), 
endothelial function (0.93), and sleep apnea (1.14) were 
not significantly different from 1. The lack of significance 
for pulse wave velocity was driven by the inclusion of age 
in the model.
There is no one factor that seems to drive all the other 
factors. The relationship between diabetes and hyperten-
sion is an excellent case in point. Further examination of 
this relationship (Fig. 2a) shows that while obesity has a 
significant impact on hypertension, diabetes appears to 
be the real driving factor. Once diabetes is present, so too 
is hypertension in more than three quarters of individu-
als, irrespective of obesity status. This is not to say there 
is no association with obesity. As seen in Fig. 2a, there is 
a systematic increase in hypertension moving from nor-
mal weight to overweight to obese in those with normal 
glucose tolerance. This pattern is more pronounced in 
those classified with prediabetes, but the pattern appears 
essentially lost in those with diabetes.
Sleep apnea, on the other hand, appears driven more 
by obesity with a smaller contribution from diabetes 
(Fig.  2b). In Fig.  2b, there is a general increase in sleep 
apnea prevalence (at any threshold) across the obesity 
classifications that is most pronounced for moderate 
to severe sleep apnea. There is a smaller contribution 
due to diabetes that appears to interact with obesity 
(z-score = −2.12, p = 0.034 from ordinal logistic regres-
sion after adjusting for age and sex) with the clearest 
patterns in those classified as overweight or obese. The 
lack of such a pattern in the normal weight group likely 
reflects the much smaller sample sizes in the normal 
weight groups in the final sample. It is noteworthy that 
of the 155 individuals classified with severe sleep apnea, 
only 18 reported regular or intermittent use of CPAP.
All indications are that these conditions and risk factors 
are developing early and in the absence of overt diabe-
tes. Illustrated in Fig. 3a, b for men and women, respec-
tively, are the relationship between prediabetes, defined 
Table 1 Population frequencies of type 2 diabetes, obesity and hypertension by age and sex among Mexican Americans 
in Starr County, Texas
a Rates for previously identified diabetes come from the representative household survey including 5230 individuals aged 20 and above
b Based on oral glucose tolerance tests on 1345 individuals having no prior history of diabetes and then weighted to what would be seen in the total population
c Population frequency among those 20 and above adjusted to the 2010 Census by the direct method
d Weighted frequencies of overweight or obesity among those with normal glucose tolerance, pre-diabetes and type 2 diabetes based on the 1609 individuals from 
the household survey participating in full examinations
e p-value based on Mantel–Haenszel Chi square testing for difference by sex after controlling for age effects. OR is the Mantel–Haenszel adjusted odds ratio
Age group Sampling (n) Type 2 diabetes Overweight and obesityd Hypertensionc
Survey OGTT Previously 
identified %a
Newly identi‑
fied %b
Total diabe‑
tes %
Pre‑ diabetes 
%b
25 ≤ BMI  
< 30 %
BMI ≥ 30 % SBP ≥ 140 or 
DBP ≥ 90 or 
current meds
Men
 20–29 585 141 1.9 2.8 4.7 22.3 37.6 38.0 5.7
 30–39 519 118 4.8 9.7 14.5 27.4 39.3 44.9 13.9
 40–49 405 103 13.1 11.8 24.9 32.9 37.4 50.3 25.6
 50–59 351 22 18.2 14.9 33.1 44.6 38.0 45.3 44.4
 60–69 254 12 22.8 19.3 42.1 38.6 29.5 51.9 70.5
 70+ 208 12 24.5 25.2 49.7 44.0 37.6 55.3 79.5
 Totals 2322 408 11.8c 11.9c 23.7c 32.8c 37.0c 46.2c 32.1c
Women
 20–29 707 263 1.4 1.9 3.3 28.5 31.9 41.1 2.7
 30–39 615 310 3.4 7.5 10.9 39.1 32.4 47.4 5.3
 40–49 565 279 10.3 10.0 20.2 40.5 29.8 57.3 21.7
 50–59 434 38 24.9 9.9 34.8 35.6 30.3 59.6 50.6
 60–69 298 32 32.9 25.2 58.1 16.3 35.6 45.0 71.2
 70+ 289 13 29.8 32.4 62.2 21.6 30.9 46.9 84.8
 Totals 2908 935 14.4c 12.3c 26.7c 31.9c 31.5c 49.5c 32.4c
 p value 0.062 0.594 0.276 0.807 0.000 0.018 0.046♂vs♀ and ORe 0.85 1.05 1.19 1.01 1.28 0.88 1.16
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Table 2 Aortic stiffness, LV mass, endothelial dysfunction and  sleep apnea by  age and  sex among  Mexican Americans 
in Starr County, Texas
a Frequencies in those with and without type 2 diabetes were weighted according to the age- and sex-specific population distributions of diabetes and no diabetes
b Population frequency among those 20 and above adjusted to the 2010 Census by the direct method
c p value based on Mantel–Haenszel Chi square testing for difference by sex after controlling for age effects. OR is the Mantel–Haenszel adjusted odds ratio
Men Aortic stiffnessa LV mass/height2.7a Endothelial dysfunc‑
tiona
Sleep apneaa
n PWV ≥ 12  
m/s %
n Mild
49–55 %
Moderate
56–63 %
Severe
≥64 %
n RHI < 1.67 % N Moderate % Severe %
30–39 24 2.1 37 4.8 4.8 1.2 39 54.1 44 15.8 16.7
40–49 53 8.3 59 11.9 3.2 1.8 64 43.1 64 21.0 21.1
50–59 67 31.7 66 23.5 8.8 6.5 72 52.4 81 27.3 33.0
60–69 41 54.7 38 10.5 8.2 3.5 52 56.2 52 31.3 9.5
70+ 16 39.7 24 31.9 11.3 20.3 24 21.6 24 6.8 36.5
Totals 201 22.3b 224 15.3b 7.0b 5.7b 251 48.6b 265 22.4b 22.8b
Women Aortic stiffnessa LV mass/height2.7a Endothelial  
dysfunctiona
Sleep apneaa
n PWV ≥ 12 % n Mild
45–51 %
Moderate
52–58 %
Severe
≥59 %
n RHI < 1.67 % N 15 ≤ AHI  
< 30 %
AHI ≥ 30 
or CPAP %
30–39 106 1.1 114 9.1 2.6 3.6 128 30.5 132 7.9 3.7
40–49 151 4.9 147 15.5 5.8 6.6 174 19.2 196 15.9 5.8
50–59 167 20.8 148 23.2 13.0 11.3 183 24.0 202 21.4 17.2
60–69 62 44.5 59 26.8 18.5 24.8 69 21.9 84 33.4 18.1
70+ 41 65.4 41 48.5 6.7 20.2 48 19.1 65 31.6 17.9
Totals 527 16.0b 509 17.8b 8.2b 9.7b 602 23.6b 679 17.9b 10.9
p value 0.216 0.172 0.308 0.003 0.000 0.356 0.000♂vs♀ and 
ORc
1.30 0.75 0.73 0.36 3.24 1.18 2.42
Table 3 Logistic regression odds ratios documenting the significance of  associations between  axis measures with  age, 
sex, diabetes, obesity and hypertension always included in the model except when one of those was the dependent vari-
able
As independent variables, obesity uses three categorizations (normal, overweight and obese), diabetes uses three (normal glucose tolerance, prediabetes and 
diabetes) while LV mass and sleep apnea use four categorizations (none, mild, moderate and severe). As dependent variables, they are all dichotomized
* p ≤ 0.05
** p ≤ 0.01
*** p ≤ 0.001
Independent Dependent
Diabetes Obesity 
BMI ≥ 30
Hypertension Aortic stiffness 
PWV ≥ 12
LV mass/ 
height2.7 moder‑
ate +
Endothelial 
dysfunction 
RHI < 1.67
Sleep apnea 
AHI ≥ 15
Age group 2.36*** 0.80*** 2.57*** 2.36*** 1.72*** 0.97 1.32***
Sex 1.48* 0.72* 1.50* 1.79* 0.75 3.27*** 2.03***
Diabetes 1.43*** 2.25*** 2.79*** 1.44* 1.24 1.34**
Obesity 1.28* 1.79*** 0.95 3.96*** 0.95 3.16***
Hypertension 3.60*** 2.20*** 4.21*** 1.47 0.60** 1.92***
Aortic Stiffness 3.86*** 0.86 4.01*** 1.19 0.59 1.12
LV mass/height2.7 1.30** 2.24*** 1.26* 1.12 0.95 1.34**
Endothelial dysfunc-
tion
1.28 1.02 0.60** 0.57 1.14 1.10
Sleep apnea 1.15 2.52*** 1.31** 1.11 1.31* 0.99
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by either fasting or 2-h post-load glucose, and obesity, 
hypertension, aortic stiffness, left ventricular hypertro-
phy, endothelial dysfunction and sleep apnea. In every 
instance except reactive hyperemia and LV mass in men, 
prediabetes is associated with a more untoward risk pro-
file. Logistic regression analyses show that prediabetes 
is a significant predictor of obesity, hypertension, aortic 
stiffness, and sleep apnea after adjusting for age and sex. 
Frequencies among men and women in Fig.  3 are only 
significantly different for reactive hyperemia and sleep 
apnea and confirm what has been reported for them in 
other studies ([41] and [8], respectively).
Discussion
The picture that emerges for this set of untoward health 
conditions is one of a large population burden coupled 
with complex interrelationships among factors. Tables 1 
and 2 show the separate burdens among Mexican Ameri-
cans, but do not capture the overall impact of this con-
stellation of diseases and risk factors. In the full sample 
of 1200, 88 % have one or more of these conditions, 70 % 
have two or more, 50 % have three or more and 26 % have 
four or more. Excluding those with diabetes, 76, 43 and 
20 % of the remainder have one, two, three or more of the 
other conditions, respectively. Furthermore, if we only 
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Fig. 2 a The association between glycemic state and hypertension 
stratified by obesity among Mexican Americans in Starr County, 
Texas demonstrating a driving role of overt diabetes. Above each 
bar are the numbers of individuals hypertensive over the number of 
total individuals in said glycemia by weight category. p values are 
those obtained via logistic regression testing the hypothesis that 
glycemia (normal, prediabetes or diabetes) is a significant predictor of 
hypertension within each weight strata while adjusting for age and 
sex. b The association between moderate or more severe sleep apnea 
(AHI ≥ 15) and glycemic state stratified by obesity among Mexican 
Americans in Starr County, Texas (NGT normal glucose tolerance, Pre 
prediabetes, Diabetes type 2 diabetes). Above each bar are the num-
bers of individuals in each sleep apnea category over the number of 
total individuals in said glycemia by weight strata. p values are those 
obtained from ordinal logistic regression testing the hypothesis that 
glycemia is a significant predictor of sleep apnea (as an ordinal vari-
able of none, mild, moderate and severe) within each weight strata 
while adjusting for age and sex
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b
Fig. 3 The impact of prediabetes on obesity, hypertension, aortic 
stiffness, left ventricular hypertrophy (moderate plus severe indexed 
by height2.7), impaired endothelial function and sleep apnea (moder-
ate plus severe) among Mexican American women (a) and men (b) in 
Starr County, Texas. Prediabetes is based on a fasting blood glucose 
(100–125 mg/dl) or 2-h post-load glucose (140–199 mg/dl) without 
consideration of HbA1c. p values are those obtained from Chi square 
statistics (or Fisher’s exact test when cell size were five or less) test-
ing the independence of prediabetes and the respective risk factor 
categorization
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consider the non-traditional risk factors of aortic stiff-
ness, LV mass, impaired reactive hyperemia, and sleep 
apnea, 74  % of those with type 2 diabetes have one or 
more untoward values for these conditions while 58 % of 
those with prediabetes and 37 % of those without diabe-
tes are so classified. Among those under age 50, these fre-
quencies are 58, 51 and 31 %, respectively, indicating that 
the development of these often occurs before the full or 
even earliest metabolic consequences of diabetes are seen 
as we know that many of these younger adults will go on 
to develop diabetes. With such high frequencies across 
the spectrum, those individuals who have yet to develop 
any axis condition may represent a group that would be 
particularly fruitful for investigation as to why they may 
have some degree of protection.
It is clear that the conditions typically associated with 
diabetes already manifest changes in the prediabetes state 
as do the newer measures. Perhaps equally striking is the 
high burden in those with normal glucose tolerance. This 
would seem to push back the metabolic changes to being 
either precursors of the changes leading to compromised 
glucose metabolism or concomitant with other physi-
ologic changes wherein glucose metabolism is only one 
of the manifestations.
With regard to classification of prediabetes we used the 
more conservative definition based on fasting and 2-h 
post-load glucose to maintain consistency with classifica-
tions from our earlier studies. A total of 304 individuals 
were classified as having prediabetes at the most recent 
examination based on fasting and 2-h post-load glucose. 
Considering HbA1c criteria [34] leads to an additional 47 
individuals classified with prediabetes. Interestingly, only 
12.3 % of those with prediabetes met the fasting, 2-h and 
HbA1c criteria. Furthermore, had we only used fasting 
glucose criteria, 36 % of those with prediabetes based on 
current criteria would have been missed. Utilizing fasting 
and 2-h post-load glucose misses 13 % while fasting glu-
cose and HbA1c combined miss 16 % albeit they miss dif-
ferent individuals. The overlap of criteria are illustrated 
in Additional file 2: Figure S1. Adding the HbA1c classi-
fied individuals had minimal effect on the magnitude of 
associations illustrated in Fig. 2a, b. Additional file 3: Fig-
ure S2a, b are equivalent to Fig. 2a, b with the exception 
that HbA1c is considered in the definition of prediabetes.
The Mexican American population of Starr County has 
undergone rapid changes in the epidemiology and impact 
of type 2 diabetes, obesity, and hypertension when com-
pared to results we reported two and three decades ago 
[42–44]. It appears that type 2 diabetes and obesity are 
on approximate 20  year doubling times. The dispropor-
tionate impact of type 2 diabetes, obesity and hyperten-
sion on the Mexican American population has been well 
documented, but there is little with regard to the other 
non-traditional risk factors documented here in the gen-
eral or other Hispanic populations. Even within Hispanic 
groups reported in the Hispanic Community Health 
Study/Study of Latinos [8], these sleep apnea results 
indicate an elevated burden among Mexican Americans 
in the socioeconomically disadvantaged border com-
munity of Starr County. Some of these differences are 
likely explained by differences in sampling, equipment, 
and age structures. Even so, these studies demonstrate 
a significant, largely unrecognized and untreated bur-
den of sleep apnea in the Mexican American population 
with consequences for other health outcomes. It is strik-
ing that 88.4 % of those who are obese and have diabetes 
have at least mild sleep apnea. These results are similar 
to the 86.6 % frequency of mild or worse sleep apnea in 
the Sleep AHEAD Study [45]. As in that study, nearly all 
of the sleep apnea among obese individuals with diabetes 
in Starr County is unrecognized. Our study and the Sleep 
AHEAD study make a compelling case for the need to 
consider sleep apnea in the routine assessment and treat-
ment of obese individuals with type 2 diabetes.
Conclusions
The full axis of untoward conditions is not only elevated 
in Starr County, but there are significant and complex 
associations among them. The patterns are consistent 
with a genesis well before overt disease classifications are 
recognized. This is most clear for prediabetes where there 
is an increasing appreciation for the need to intervene 
as a prevention and control strategy for coronary artery 
disease [46] and other conditions [47]. Whether these 
associations are mediated by common underlying factors 
or whether there exist multiple mechanisms remains to 
be seen. Answers will have significant public health and 
translational implications.
Additional files
Additional file 1. The frequencies by age and sex of aortic stiffness, LV 
mass, endothelial dysfunction and sleep apnea for those without type 2 
diabetes (Table S1) and those with type 2 diabetes (Table S2).
Additional file 2: Figure S1. Overlap of prediabetes classifications 
based on fasting blood glucose (100–125 mg/dl), 2-h post-load glucose 
(140–199 mg/dl and HbA1c (5.7–6.4 %) among Mexican Americans with-
out diabetes in Starr County, Texas.
Additional file 3: Figure S2. The impact of prediabetes on obesity, 
hypertension, aortic stiffness, left ventricular hypertrophy (moderate plus 
severe indexed by height2.7), impaired endothelial function and sleep 
apnea (moderate plus severe) among Mexican American women (2a) and 
men (2b) in Starr County, Texas. Prediabetes based on fasting blood glu-
cose (100–125 mg/dl) or 2-h post-load glucose (140–199 mg/dl) or HbA1c 
(5.7–6.4 %). P values are those obtained from Chi square statistics (or 
Fisher’s Exact Test when cell size were five or less) testing the independ-
ence of prediabetes and the respective risk factor categorization.
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